Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Other divalent cations refers to a broad category of positively charged metal ions with a valence of +2, excluding the primary physiological ions like calcium and magnesium. This group typically includes trace elements such as zinc (Zn2+), copper (Cu2+), iron (Fe2+), manganese (Mn2+), and cobalt (Co2+), as well as toxic heavy metals like lead (Pb2+) and cadmium (Cd2+). These ions serve as essential cofactors for a vast array of enzymes and transcription factors, playing critical roles in DNA synthesis, antioxidant defense, and cellular signaling. While they are necessary for health in trace amounts, their dysregulation is linked to various pathologies, including neurodegenerative diseases and metabolic disorders. In a pharmacological context, this entry is considered a non-specific grouping rather than a single therapeutic target, often used to describe the binding of chelating agents or the supplementation of mineral deficiencies.
Chelation of excess ions or supplementation to restore physiological levels.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other divalent cations.